 |
The 130th Annual Meeting of APHA |
|
The 130th Annual Meeting of APHA |
Lee Crandall, PhD1, Hayley B. Tobias, MPH2, Harlan P. Wolfe, MSW1, and Clyde B. McCoy, PhD1. (1) Department of Epidemiology and Public Health, University of Miami, P.O Box 016069, Miami, FL 33101, (305) 243-3021, lcrandal@med.miami.edu, (2) Dept of Epidemiology and Public Health, University of Miami, PO Box 016069, Miami, FL 33101
This paper describes prevalence of use of MDMA (ecstasy) and other “club drugs” (rohypnol, GHB, ketamines) in Florida adolescents, assesses correlates of lifetime use, and examines the impact of risk and protective factors. A statewide sample of approximately 8,300 participated in the 2001 Florida Youth Substance Abuse Survey. At each grade level, respondents reported lower levels of MDMA use than in national Monitoring the Future data for 2000. Use of each club drug was significantly and relatively strongly correlated with use of the other club drugs, with correlation coefficients ranging from .29 to .45. Lifetime use of each club drug also showed relatively strong correlation with use of relatively infrequent drugs of abuse such as hallucinogenic mushrooms, narcotics (other than heroin), depressants and cocaine. Ecstasy use was more strongly correlated with use of alcohol and tobacco than was use of the other club drugs. Multivariate stepwise logistic regression analysis of risk and protective factors showed that peer ATOD use and early initiation of antisocial behavior were strong risk factors for lifetime use of each drug. A family history of antisocial behavior was an additional risk factor for use of ecstasy and ketamines, and individual attitudes favorable to ATOD use were a risk factor for ecstasy and rohypnol. Social refusal skills were a strong protective factor for rohypnol and ketamines, but not for GHB or ecstasy. Demographic factors (ethnicity, gender, grade) showed little influence on lifetime use when the effects of risk and protective factors were held constant.
Learning Objectives: At the close of this session the participant will be able to
Keywords: Drug Abuse, Adolescent Health
Presenting author's disclosure statement:
Organization/institution whose products or services will be discussed: none
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.